Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

002821 Asymchem Laboratories(Tianjin)Co.,Ltd.

Closed 04-17 15:00:00

114.41

-3.00

-2.56%

High117.98	Low114.15	Vol8.13M
Open117.22	D1 Closing117.41	Amplitude3.26%
Mkt Cap41.30B	Tradable Cap36.27B	Total Shares361.00M
T/O938.00M	T/O Rate2.56%	Tradable Shares317.00M
P/B2.4	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"Asymchem Laboratories(Tianjin)Co.,Ltd.","latestPrice":114.41,"timestamp":1776409437000,"preClose":117.41,"halted":0,"volume":8128919,"delay":0,"changeRate":-0.0256,"floatShares":317000000,"shares":361000000,"eps":3.6473,"marketStatus":"Closed","change":-3,"latestTime":"04-17 15:00:00","open":117.22,"high":117.98,"low":114.15,"amount":938000000,"amplitude":0.0326,"askPrice":114.42,"askSize":7,"bidPrice":114.41,"bidSize":11,"shortable":0,"etf":0,"ttmEps":3.6473,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":5,"adr":0,"adjPreClose":117.41,"symbolType":"stock","openAndCloseTimeList":[[1776389400000,1776396600000],[1776402000000,1776409200000]],"highLimit":129.15,"lowLimit":105.67,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360874970,"isCdr":false,"pbRate":2.4,"roa":"--","peRate":31.36841,"roe":"6.58%","epsLYR":3.16,"committee":0.21519,"marketValue":41288000000,"turnoverRate":0.0256,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2026-04-20.","hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"ASYMCHEM","latestPrice":98.45,"timestamp":1776413294008,"preClose":100.7,"halted":0,"volume":286760,"delay":0,"premium":"-25.21"},"floatMarketCap":36273000000},"requestUrl":"/m/hq/s/002821/tweets","defaultTab":"tweets","newsList":[{"id":"2628207889","title":"Asymchem Laboratories held extraordinary general meeting to vote on share repurchase, articles changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2628207889","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628207889?lang=en_us&edition=fundamental","pubTime":"2026-04-17 22:25","pubTimestamp":1776435943,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories held its first extraordinary general meeting of 2026 on April 17, 2026.Shareholders adopted two resolutions to repurchase and cancel part of restricted A shares granted under 2025 A Share Scheme, covering repurchase-and-cancellation proposals dated Dec. 19, 2025, and March 13, 2026.Meetings also passed amendments to Articles of Association, with changes taking immediate effect.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL80s2qt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","BK0239","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191346325","title":"Asymchem Laboratories Expands TIDES Production Capacity, Enhancing Drug Service Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=1191346325","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191346325?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:31","pubTimestamp":1776321113,"startTime":"0","endTime":"0","summary":"On April 14, the Administrative Committee of Tianjin Economic-Technological Development Area signed a cooperation memorandum with Asymchem Laboratories (Tianjin) Co., Ltd. to continuously expand the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0132","002821","BK1191","06821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130637500","title":"J.P. Morgan Increases Stake in Asymchem by 95,600 Shares at HK$97.68 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1130637500","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130637500?lang=en_us&edition=fundamental","pubTime":"2026-04-14 07:50","pubTimestamp":1776124249,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on April 8, J.P. Morgan increased its holding in Asymchem (06821) by 95,600 shares. The transaction was executed at a price of HK$97.6752 per...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0942090050.USD","LU1328615791.USD","06821","LU1244550577.SGD","LU1720051108.HKD","LU2552382215.SGD","LU1162221912.USD","IE00BKVL7J92.USD","LU0203347892.USD","LU2462157665.USD","LU1629891620.HKD","LU2505996681.GBP","LU1974910355.USD","BK0132","LU2552382058.USD","LU0417517546.SGD","LU2237443549.SGD","LU1267930490.SGD","IE00BJLML261.HKD","JPM","IE00BJTD4V19.USD","IE00B1XK9C88.USD","LU1548497426.USD","LU2242649171.HKD","LU2236285917.USD","IE00BLSP4452.SGD","LU2746668974.SGD","BK0239","LU1064131342.USD","LU0345769631.USD","LU0640476718.USD","LU0211331839.USD","LU0265550359.USD","LU0238689110.USD","LU0106261372.USD","LU1551013342.USD","LU2106854487.HKD","LU1261432733.SGD","SG9999002232.USD","LU2237443622.USD","BK4516","IE00BJTD4N35.SGD","IE0034235295.USD","LU1145028129.USD","LU0048584097.USD","LU1280957306.USD","LU2357305700.SGD","BK4581","BK4533","IE00B3S45H60.SGD","LU2023250504.SGD","LU1496350171.SGD","LU2552382132.HKD","LU0265550946.USD","LU0345769128.USD","BK4534","LU0345770993.USD","LU2023250330.USD","LU2756315664.SGD","LU1084165304.USD","BK4504","LU2237443895.HKD","LU0820562030.AUD","IE00BWXC8680.SGD","LU0868494617.USD","IE00BKDWB100.SGD","LU2456880835.USD","LU0882574139.USD","LU1668664300.SGD","LU2264538146.SGD","LU0267386448.USD","LU0496365809.HKD","LU2237443382.USD","IE00BFXG1179.USD","IE00BHPRN162.USD","IE00BLSP4239.USD","LU0320765646.SGD","IE000M9KFDE8.USD","LU0149725797.USD","BK4207","LU0211326839.USD","LU2430703095.HKD","LU2756315318.SGD","IE00BYXW3230.USD","LU0256863811.USD","LU2211815571.USD","LU0787776722.HKD","BK4566","LU0323591593.USD","LU1116320901.HKD","LU2237443465.HKD","LU2430703178.SGD","LU0820561909.HKD","LU1670628061.USD","LU1119994496.HKD","IE00BDRTCR15.USD","IE0034235303.USD","LU0868494708.USD","JPO","LU0208291251.USD","LU1244550221.USD","002821","LU0211328371.USD","LU2430703251.USD","LU0320765489.SGD","IE00BDCRKT87.USD","LU0170899867.USD","LU2381873111.SGD","LU1366192091.USD","IE00BBT3K403.USD","LU1116320737.USD","LU0971096721.USD","LU1914381329.SGD","LU0211326755.USD","LU2237443978.SGD","LU2746668461.USD","IE00B1BXHZ80.USD","LU1032466523.USD","LU1363072403.SGD","LU2505996509.AUD","LU1551013425.SGD","IE00BN8TJ469.HKD","IE00BZ1G4Q59.USD","LU0006306889.USD","LU1244550494.USD","LU1894683264.USD","IE00B775SV38.USD","LU0310799852.SGD","BK4550","LU0203345920.USD","JPMO","LU0976567544.SGD","LU0689472784.USD","LU1917777945.USD","LU2054465674.USD","LU0251132253.USD","LU2023250843.SGD","LU1988902786.USD","SG9999002224.SGD","LU0345770308.USD","LU0211327993.USD","LU2213496289.HKD","LU0106831901.USD","LU0215105999.USD","LU1720051017.SGD","LU2417539215.USD","LU2592432038.USD","LU0070302665.USD","LU0683600562.USD","BK4585","BK1191","EWH","LU1496350502.SGD","LU1894683348.USD","LU1670627923.USD","IE0034235188.USD","LU0820561818.USD","LU0234572021.USD","LU0943347566.SGD","LU0964807845.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627433173","title":"Asymchem schedules board meeting to review first-quarter results","url":"https://stock-news.laohu8.com/highlight/detail?id=2627433173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627433173?lang=en_us&edition=fundamental","pubTime":"2026-04-13 16:33","pubTimestamp":1776069228,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories  will hold a board meeting on April 27, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL89bphv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0132","002821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169382027","title":"Norges Bank Reduces Stake in Asymchem by 263,200 Shares at HK$104.64 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1169382027","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169382027?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:40","pubTimestamp":1775648439,"startTime":"0","endTime":"0","summary":"On April 2, Norges Bank sold 263,200 shares of Asymchem (06821) at a price of HK$104.6389 per share, according to the latest data from the Hong Kong Stock Exchange. The total transaction value was...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","002821","06821","BK0239","LU1328615791.USD","BK0132","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181953409","title":"Bocom International Maintains Buy Rating on Asymchem, Raises Target Price to HK$123.2","url":"https://stock-news.laohu8.com/highlight/detail?id=1181953409","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181953409?lang=en_us&edition=fundamental","pubTime":"2026-04-03 15:00","pubTimestamp":1775199649,"startTime":"0","endTime":"0","summary":"Bocom International released a research report stating that, based on Asymchem Laboratories (Tianjin) Co., Ltd. (06821) revised 2026 performance guidance, it has raised its profit forecasts for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","EWH","LU1328615791.USD","BK0132","BK0239","002821","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153294586","title":"Asymchem Laboratories Shares Experience Abnormal Trading Fluctuations, No Undisclosed Matters","url":"https://stock-news.laohu8.com/highlight/detail?id=1153294586","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153294586?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:44","pubTimestamp":1775043867,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories (06821) announced that its stock recorded cumulative closing price deviations exceeding 20% over two consecutive trading days on March 31, 2026, and April 1, 2026. According to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06821","LU1328615791.USD","002821","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194363396","title":"Robust CXO Earnings Boost Performance: Huabao Fund's HK Connect Medical ETF and Medical ETF Rise Up to 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194363396","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194363396?lang=en_us&edition=fundamental","pubTime":"2026-03-31 10:11","pubTimestamp":1774923070,"startTime":"0","endTime":"0","summary":"Leading CXO companies have released better-than-expected annual reports. On the morning of March 31, the A-share and H-share healthcare sectors advanced, with the Medical ETF (512170) and the HK...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","159828","BK1191","CXO","LU1328615791.USD","603127","002821","BK1141","BK0239","BK1576","BK0216","06127","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125164007","title":"Asymchem Laboratories Reports Annual Profit Growth of 19.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125164007","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125164007?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:56","pubTimestamp":1774882582,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories (06821) announced its financial results for the year ended December 31, 2025. The group recorded revenue of approximately RMB 6.67 billion, representing a year-on-year increase...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","LU1328615791.USD","002821","BK1191","06821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623346566","title":"Asymchem Laboratories proposes final dividend of RMB 13 per 10 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2623346566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623346566?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:02","pubTimestamp":1774879352,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories proposed final dividend for fiscal 2025 of RMB 13 per 10 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL2fDgTM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","LU1328615791.USD","BK0239","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623345064","title":"Asymchem FY25 net profit climbs 19.35% to RMB 1.1 billion; revenue rises to RMB 6.7 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2623345064","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623345064?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:54","pubTimestamp":1774878884,"startTime":"0","endTime":"0","summary":"Asymchem posted FY2025 net profit attributable to shareholders up 19.35% to RMB 1.13 billion.Gross profit margin widened 0.56 percentage points to 41.59%.Adjusted net profit attributable to shareholders jumped 56.09% to RMB 1.25 billion; board proposed final dividend of RMB 13 per 10 shares totaling about RMB 468 million.Order backlog climbed 31.65% to USD 1.39 billion; 2026 revenue growth forecast set at 19%-22%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL3pkqw4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","LU1328615791.USD","BK0239","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312586","title":"BRIEF-Asymchem Laboratories (Tianjin) 2025 Net Profit Up 19.4% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312586","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312586?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:44","pubTimestamp":1774871089,"startTime":"0","endTime":"0","summary":"BRIEF-Asymchem Laboratories (Tianjin) 2025 Net Profit Up 19.4% Y/YMarch 30 (Reuters) - Asymchem Laboratories (Tianjin) Co Ltd 002821.SZ:2025 NET PROFIT UP 19.4% Y/YSource textFurther company coverage: 002821.SZ (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL4N40I10T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","BK0239","LU1328615791.USD","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142853209","title":"Schroders PLC Increases Stake in Asymchem Laboratories with 88,500 Shares Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1142853209","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142853209?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:10","pubTimestamp":1774869024,"startTime":"0","endTime":"0","summary":"On March 26, Schroders PLC purchased an additional 88,500 shares of Asymchem Laboratories (06821) at an average price of HK$79.0296 per share. The total transaction value amounted to approximately...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1191","BK0132","06821","EWH","002821","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622076946","title":"Asymchem Laboratories Tianjin H shareholders vote on proxy appointments; meeting set for April 17, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622076946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622076946?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:54","pubTimestamp":1774443292,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories will ask H shareholders to vote by poll on special resolutions covering the repurchase and cancellation of part of the restricted A Shares granted under the 2025 A Share Scheme, including actions proposed on 19 December 2025 and 13 March 2026.The meeting will also vote on the Proposed Amendments to the Articles of Association.The proposals are scheduled for a vote at the first H Shares Class Meeting of 2026 on 17 April 2026.Shareholders appointing a proxy are advised to vote in favor of the special resolutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL8R75V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002821","LU1328615791.USD","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619535064","title":"Asymchem Laboratories Tianjin schedules board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2619535064","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619535064?lang=en_us&edition=fundamental","pubTime":"2026-03-16 16:31","pubTimestamp":1773649881,"startTime":"0","endTime":"0","summary":"A board meeting of Asymchem is scheduled for 30 March 2026.The meeting agenda includes reviewing the annual results for the year ended 31 December 2025.Directors are expected to consider a recommendation on a final dividend at the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL7R6wtS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","002821","LU1328615791.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111124664","title":"Asymchem to Repurchase and Cancel Restricted A-Shares Under 2025 Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1111124664","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111124664?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:00","pubTimestamp":1773406819,"startTime":"0","endTime":"0","summary":"Asymchem (06821) announced that on March 13, 2026, its board of directors reviewed and approved a proposal regarding the repurchase and cancellation of certain restricted shares under the 2025...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0239","06821","399300","LU1328615791.USD","002821","159982","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619197633","title":"Asymchem Laboratories Tianjin to Cancel 61,000 Restricted A Shares in Capital Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2619197633","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619197633?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:50","pubTimestamp":1773406206,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories  Co., Ltd. said its board approved the repurchase and cancellation of 61,000 restricted A shares granted under its 2025 A Share Scheme that remain locked, after five incentive participants resigned. The cancellation covers 56,000 shares from the initial grant and 5,000 shares from the reserved grant, with repurchase prices adjusted to RMB36.42 per share and RMB53.24 per share, respectively, for total consideration of RMB2.31 million from internal funds. Following the cancellation, the company’s A-share capital will be reduced to 332,946,460 shares from 333,007,460, and total issued shares will fall to 360,780,970 from 360,841,970.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asymchem Laboratories Tianjin Co. Ltd","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL51xb6n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1328615791.USD","BK0132","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618746629","title":"AsymBio Completes its Dual-Site, One-Center Network with Fengxian Commercial Manufacturing Site Operational, Enhancing End-to-End Biologics CDMO Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2618746629","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618746629?lang=en_us&edition=fundamental","pubTime":"2026-03-09 21:00","pubTimestamp":1773061200,"startTime":"0","endTime":"0","summary":"SHANGHAI, March  09, 2026  (GLOBE NEWSWIRE) -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ /6821.HK), recently announced that its Fengxian commercial manufacturing site in Shanghai ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251899/0/en/AsymBio-Completes-its-Dual-Site-One-Center-Network-with-Fengxian-Commercial-Manufacturing-Site-Operational-Enhancing-End-to-End-Biologics-CDMO-Capabilities.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK4139","002821","BK0132","CDMO","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614408983","title":"BRIEF-Citigroup's Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Increases To 11.67% On Feb 19 From 9.34%, HKEX Filing Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2614408983","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614408983?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:45","pubTimestamp":1772019938,"startTime":"0","endTime":"0","summary":"BRIEF-Citigroup's Long Position In H-Shares Of Asymchem Laboratories  Increases To 11.67% On Feb 19 From 9.34%, HKEX Filing ShowsFeb 25  - HKEX:CITIGROUP'S LONG POSITION IN H-SHARES OF ASYMCHEM LABORATORIES  6821.HK INCREASES TO 11.67% ON FEB 19 FROM 9.34%Further company coverage: 6821.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0239","002821","LU1328615791.USD","BK0132","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614086522","title":"Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin)  Increases to 11.67% on Feb 19 From 9.34% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2614086522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614086522?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:31","pubTimestamp":1772019068,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06821","BK0132","002821","LU1328615791.USD","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","stockEarnings":[{"period":"1week","weight":-0.0566},{"period":"1month","weight":0.1503},{"period":"3month","weight":0.066},{"period":"6month","weight":0.1108},{"period":"1year","weight":0.8726},{"period":"ytd","weight":0.2311}],"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"36087万元","compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":-0.0028},{"period":"3month","weight":-0.0123},{"period":"6month","weight":0.0551},{"period":"1year","weight":0.2351},{"period":"ytd","weight":0.0208}],"survey":"　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。","serverTime":1776466187491,"listedPrice":30.53,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Asymchem Laboratories(Tianjin)Co.,Ltd.(002821) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Asymchem Laboratories(Tianjin)Co.,Ltd.,002821,Asymchem Laboratories(Tianjin)Co.,Ltd.股票,Asymchem Laboratories(Tianjin)Co.,Ltd.股票老虎,Asymchem Laboratories(Tianjin)Co.,Ltd.股票老虎国际,Asymchem Laboratories(Tianjin)Co.,Ltd.行情,Asymchem Laboratories(Tianjin)Co.,Ltd.股票行情,Asymchem Laboratories(Tianjin)Co.,Ltd.股价,Asymchem Laboratories(Tianjin)Co.,Ltd.股市,Asymchem Laboratories(Tianjin)Co.,Ltd.股票价格,Asymchem Laboratories(Tianjin)Co.,Ltd.股票交易,Asymchem Laboratories(Tianjin)Co.,Ltd.股票购买,Asymchem Laboratories(Tianjin)Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Asymchem Laboratories(Tianjin)Co.,Ltd.(002821),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Asymchem Laboratories(Tianjin)Co.,Ltd.(002821) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction